SiePortal is not yet available in the selected region
Please mind, SiePortal is not yet available in the region you selected. If you continue, you will be taken to the platform Industry Mall, which will successively be replaced by SiePortal also in that region.
In the selected region, SiePortal is available
Please mind, in the region you selected, our Industry Mall is already replaced by its successor, SiePortal. If you continue, you will be taken to SiePortal, which will successively replace Industry Mall also in other regions.
Use our online form for specific solution suggestions or send your technical question directly to a product specialist in the Technical Support.
Create request
Status of your requests
Track the status of your request online. An overview of your request can be found here:
Status of your requests
Status of your requests
SIMATIC S7-300, CPU 317F-2DP, CENTRAL PROCESSING UNIT WITH 512 KBYTE WORKING MEMORY, 1. INTERFACE MPI/DP 12MBIT/S, 2. INTERFACE DP-MASTER/SLAVE, MICRO MEMORY CARD NECESSARY FOR USE WITH SOFTWARE OPTION S7 DISTRIBUTED SAFETY V5.2 SP1 AND HIGHER
SIMATIC S7-300, CPU 317F-2DP, CENTRAL PROCESSING UNIT WITH 512 KBYTE WORKING MEMORY, 1. INTERFACE MPI/DP 12MBIT/S, 2. INTERFACE DP-MASTER/SLAVE, MICRO MEMORY CARD NECESSARY FOR USE WITH SOFTWARE OPTION S7 DISTRIBUTED SAFETY V5.2 SP1 AND HIGHER
Product family
Not available
Product Lifecycle (PLM)
PM500:Discontinued Product or end of PLM & Support
SIMATIC S7-300, CPU 317F-2DP, Central processing unit with 1.5 MB work memory, 1st interface MPI/DP 12 Mbit/s, 2nd interface DP master/slave Micro Memory Card required Can be used with software package S7 Distributed Safety V5.2 SP1 or higher
Price data
Region Specific PriceGroup / Headquarter Price Group
There is currently no information on SVHC (Substances of Very High Concern http://echa.europa.eu/web/guest/candidate-list-table) from the supply chain and our established procedures for screening our products for Substances of Very High Concern.
We compare our products regularly with the information of the upstream users with regard to the substances indicated in the candidate list in accordance with the requirements of the REACH regulation. As soon as we have new findings, our information will be updated accordingly.
